Bio Protocol

19 days ago

https://t.co/ySoHpxqOUw

20

122

23

4

35K

BioProtocol retweeted

1 day ago

Highlights and key takeaways from Day 2 of DeSci Berlin 2026👇 → @vitarnabio targets a mutation tied to both cancer risk and accelerated aging, one drug, two disease mechanisms. Early mouse data already shows a 4x increase in tissue uptake across the heart, brain, and liver. → Most AI in drug discovery still needs a human to check the data, submit the order, and read the result. @peptai_ removes all three, designing candidates, paying a wet lab directly through x402, and reading results back with no human in the loop. Every candidate gets minted onchain as IP through @Molecule_sci, so the trail survives even if the experiment fails. → Open Labs lets a researcher post a single hypothesis and get real feedback from a focused community before any token or funding exists. Stake tokens behind a project, and the yield flows directly to fund the research while the principal stays untouched. → On the panel about closing the loop between AI design and the wet lab, one constraint kept coming up. Biology lacks perturbation data, real records of what happens when a specific sequence actually gets changed. Agents can propose endless candidates, but proving any of them still runs on lab time. → @adaptyvbio turned wet lab validation into an API call, send a protein sequence, get real binding data back in days. To test it, they pitted AI agents against human protein designers on the same target at a hackathon. The agents matched the best humans in the room, and the top two performers ran on GPT and Grok, no specialized biology model required. Full talks here ↓

3

26

9

4

2K

BioProtocol retweeted

2 days ago

Highlights and key takeaways from Day 1 of DeSci Berlin 2026👇 → @paulkhls: Drug discovery costs $2.5B and takes 10–15 years per approval. Most of that is bureaucracy, not biology. 90–96% of trials fail and half never get published. → AI-designed peptide binders cost as little as $7 per design run, generating dozens of candidates at once. What used to take months and tens of thousands of dollars now takes hours. The economics of early drug discovery just collapsed by orders of magnitude. → Science is sitting on $21T of untapped real-world asset value, but DeSci's entire ecosystem AUM is only ~$40M. Crypto-native fundraising has already deployed $6.1M across 125 projects with 30,000+ community members and shows that the model works. What's missing is capital. → @vitadao funded @Mykalt45's early research through an IP-NFT-anchored grant. It spun into Aeon Bio , which filed one of the first end-to-end DeSci patents. His other company, CrossBridgeBio, sold to @EliLillyandCo for $300M. → @dermadao sells two real products today, Moon Drops and Sun Drops. Dongsinne Sohn built the project from her personal experience with severe eczema. Chronic skin conditions are too small for pharma and too niche for big beauty, the exact constraint DeSci is positioned to fill. → @foresightinst's warning: Fable 5 access got pulled by export order with 24 hours' notice. If you don't host the model, you don't control your access to it, a hard lesson for anyone building on rented intelligence. Less than 5% of Africa's AI researchers have frontier model access. The gap is growing wider. → For 50 years, the best documented way to extend a mouse's life was calorie restriction, worth about 4 extra months. @aubreydegrey's team matched that by stacking several damage-repair therapies instead, and proved for the first time that the effects compound. Next target: 12 months. Full talks ↓

4

38

15

6

5K

3 days ago

https://t.co/0zISeOBO1x

Unlocking liquid science markets through tokenized IP

3 days ago

DeSci Berlin 2026 - Day 2 https://t.co/V3y9zyiAdL

1

65

10

1

6K

1

8

3

0

2K

Who to follow

Molecule

@Molecule_sci

PsyDAO

@psy_dao

Decentralizing psychedelic science and culture | https://t.co/sODZii1wzM | 💜

ValleyDAO

@valley_dao

ValleyDAO is a leading DeSci platform funding and accelerating climate-focused biotech research. 👉 Get $GROW on ETH & SOL: https://t.co/QkSSkwtE1j

3 days ago

How does science go from idea to funded execution? At DeSci Berlin, we announced that Bio is building OpenLabs, a coordination and collaboration layer where humans and agents turn scientific ideas into funded execution. What OpenLabs brings: • A shared surface where humans and agents collaborate on scientific ideas • Community voting and coordination that turns posts into funded projects • BioAgents that maintain project continuity and drive research forward Flagship projects include RheumaAI, AI research agent for rheumatology and @peptai_ peptide discovery & more. More soon! Watch the full DeSci Berlin livestream below ↓

10

101

16

5

5K

BioProtocol retweeted

3 days ago

Two days of talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more! A huge thank you to our speakers, partners, and everyone who showed up. Couldn't make it this year? Watch the full talks ↓

DeSciBerlin's tweet photo. Two days of talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more!

A huge thank you to our speakers, partners, and everyone who showed up.

Couldn't make it this year? Watch the full talks ↓ https://t.co/qczjROX0Lx

1

30

5

4

2K

3 days ago

Revealing what we have been building, live now at DeSci Berlin! Stay tuned.

3 days ago

Yield-routed funding for science. Ryan is on stage now introducing OpenLabs, @BioProtocol 's new platform, and how OpenLabs Vaults work. A surface where a scientific idea can meet collaborators, attract capital, and become a funded experiment, without ever leaving the feed. More on this soon!

DeSciBerlin's tweet photo. Yield-routed funding for science. Ryan is on stage now introducing OpenLabs, @BioProtocol 's new platform, and how OpenLabs Vaults work.

A surface where a scientific idea can meet collaborators, attract capital, and become a funded experiment, without ever leaving the feed.

More on this soon!

0

13

2

0

5K

3

59

7

2

4K

BioProtocol retweeted

3 days ago

"From DeSci to Drug Development: How ARTAN Bio and $VITARNA Are Rewriting Biotech Funding to Capture Upside Earlier" Michael @Mykalt45 on stage now talking about the acquisition of his biotech company CrossBridge which was sold to Eli Lilly for up to $300M.

DeSciBerlin's tweet photo. "From DeSci to Drug Development: How ARTAN Bio and $VITARNA Are Rewriting Biotech Funding to Capture Upside Earlier"

Michael @Mykalt45 on stage now talking about the acquisition of his biotech company CrossBridge which was sold to Eli Lilly for up to $300M. https://t.co/Az7PZEx0vd

1

22

10

1

2K

BioProtocol retweeted

3 days ago

Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin! How does it work when token holders can also become equity shareholders holding both simultaneously? Exploring the compliant path from community to cap table.

DeSciBerlin's tweet photo. Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin!

How does it work when token holders can also become equity shareholders holding both simultaneously?

Exploring the compliant path from community to cap table. https://t.co/2j6nbSHAbc

1

21

7

0

2K

3 days ago

Day 2 of DeSci Berlin starts NOW! Today's lineup covers biotech funding, encrypted longevity data, peptide discovery, and the legal side of self-driving science. Join us onsite or watch the livestream: https://t.co/ZfG1pucmr7

4

64

13

0

4K

3 days ago

DeSci Berlin 2026 - Day 2 https://t.co/V3y9zyiAdL

1

65

10

1

6K

BioProtocol retweeted

4 days ago

That's a wrap on day 1 at DeSci Berlin! Thanks for following along. Day 2 brings drug development funding, peptide discovery, encrypted longevity data, and the legal side of self-driving science. See tomorrow's agenda ↓

DeSciBerlin's tweet photo. That's a wrap on day 1 at DeSci Berlin!

Thanks for following along. Day 2 brings drug development funding, peptide discovery, encrypted longevity data, and the legal side of self-driving science.

See tomorrow's agenda ↓ https://t.co/jdRrwGi10f

2

32

11

0

2K

4 days ago

We're back LIVE for the afternoon sessions of DeSci Berlin with speakers from @dermadao, @foresightinst, @Molecule_sci and more! Join us onsite or tune into the livestream: https://t.co/HsBzhQZ8s1

4 days ago

DeSci Berlin 2026 - Day 1 https://t.co/KMqNKV4yYN

3

93

25

4

12K

7

67

10

1

3K

BioProtocol retweeted

4 days ago

"The Future of Science is Autonomous" The fifth edition of DeSci Berlin has officially been opened by @paulkhls.

1

41

13

1

2K

4 days ago

2

19

4

0

2K

4 days ago

We’re LIVE at DeSci Berlin @BerBlockWeek Streaming today's talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more! Full agenda below. WATCH it live ↓

4 days ago

DeSci Berlin 2026 - Day 1 https://t.co/KMqNKV4yYN

3

93

25

4

12K

10

83

10

1

4K

4 days ago

DeSci Berlin 2026 - Day 1 https://t.co/KMqNKV4yYN

3

93

25

4

12K

5 days ago

RSVP now: https://t.co/UlB3Kd3uiN

0

9

2

0

1K

5 days ago

DeSci Berlin is TOMORROW! Join biotech leaders, scientists, AI researchers exploring the next phase of DeSci + AI. Register to attend or watch the livestream ↓

5 days ago

The 5th edition of https://t.co/BGuYlyRIFm kicks off TOMORROW! From AI robotics in the wet lab, agentic swarms for science, longevity research, to peptide discovery powered by AI agents & more! See the final program and register below ↓

DeSciBerlin's tweet photo. The 5th edition of https://t.co/BGuYlyRIFm kicks off TOMORROW!

From AI robotics in the wet lab, agentic swarms for science, longevity research, to peptide discovery powered by AI agents & more!

See the final program and register below ↓ https://t.co/ONJYwBUxkw

3

24

7

3

6K

6

100

18

1

5K

BioProtocol retweeted

PeptAI

@peptai_

6 days ago

LIVE NOW! We're talking peptides, autonomous discovery, and what's coming next for PeptAI. Join us: https://t.co/mpxvibFr0l

5

25

7

2

2K